Original Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Aug 16, 2011; 3(8): 162-170
Published online Aug 16, 2011. doi: 10.4253/wjge.v3.i8.162
Table 2 Screening performance of the two esophagogastroduodenoscopies in subjects with or without Helicobacter pylori infection (mean ± SD) n (%)
Total subjects (H. pylori analyzed)H. pylori
PositiveNegative
Screened by transnasal EGD
Screened subjects1280510770
Age (yr)53.4 ± 15.456.8 ± 13.6c50.2 ± 14.3
Males623 (48.7)a268 (52.5)a355 (46.1)a
Smokers247 (19.3)118 (23.1)c129 (16.7)a
Subjects with gastric neoplasia/DR21/0.016416/0.0314c5/0.00649
Location of neoplasia (U/M/L)7/6/84/6/63/0/2
Adenoma cases/DR3/0.00233/0.005890/0
Size of adenoma (mm)9.7 ± 4.09.7 ± 4.00
Cancer cases/DR18/0.014113/0.0255c5/0.00649
Size of cancer (mm)31.2 ± 19.525.5 ± 13.346.0 ± 28.2
Morphological cancer type (I-IIa/IIb/IIc-III/Ad)6/1/4/75/0/4/41/1/0/3
With intestinal-type cancer16 (88.9)12 (92.3)4 (80)
Depth of invasion (m/sm/pm-)5/6/74/5/41/1/3
With early cancer12 (66.7)10 (76.9)2 (40)
Screened by transoral EGD
Screened subjects17076921015
Age (yr)53.5 ± 15.456.3 ± 14.7c51.8 ± 14.8
Males655 (38.4)298 (43.1)357 (35.2)
Smokers354 (20.7)141 (20.3)213 (21.0)
Subjects with gastric neoplasia/DR33/0.019326/0.0376c6/0.00591
Location of neoplasia (U/M/L)12/8/1210/8/92/0/3
Adenoma cases/DR9/0.00525/0.007224/0.00394
Size of adenoma (mm)10.8 ± 7.913 ± 11.510 ± 4.08
Cancer cases/DR23/0.013521/0.0303c2/0.00197
Size of cancer (mm)22.3 ± 12.823.2 ± 13.420 ± 0
Morphological cancer type (I-IIa/IIb/IIc-III/Ad)6/0/12/56/0/10/50/0/2/0
With intestinal-type cancer15 (65.2)14 (66.7)1 (50)
Depth of invasion (m/sm/pm-)15/3/513/3/52/0/0
With early cancer18 (78.3)14 (76.2)2 (100)